Two largely non-overlapping groups were observed among the 106 breast tumors analyzed, one with moderate TERT overexpression (up to ≈25-fold compared to controls; 46%) and the other with high-level overexpression (≈32- to 810-fold; 54%). The gene discussed is TERT; the disease is breast neoplasm.